Circulating Amino Acids and Acylcarnitines Correlated With Different Cac Score Ranges in Diabetic Postmenopausal Women Using Lc–Ms/Ms Based Metabolomics Approach Publisher Pubmed



Hosseinkhani S^{1, 2} ; Salari P³ ; Bandarian F⁴ ; Asadi M⁵ ; Shirani S⁶ ; Najjar N¹ ; Dehghanbanadaki H⁷ ; Pasalar P⁷ ; Razi F⁸ Show Affiliations
Source: BMC Endocrine Disorders Published:2022

Abstract

Background: Diabetes mellitus (DM) and its cardiovascular disease (CVD) complication are among the most frequent causes of death worldwide. However, the metabolites linking up diabetes and CVD are less understood. In this study, we aimed to evaluate serum acylcarnitines and amino acids in postmenopausal women suffering from diabetes with different severity of CVD and compared them with healthy controls. Methods: Through a cross-sectional study, samples were collected from postmenopausal women without diabetes and CVD as controls (n = 20), patients with diabetes and without CVD (n = 16), diabetes with low risk of CVD (n = 11), and diabetes with a high risk of CVD (n = 21) referred for CT angiography for any reason. Metabolites were detected by a targeted approach using LC–MS/MS and metabolic -alterations were assessed by applying multivariate statistical analysis. The diagnostic ability of discovered metabolites based on multivariate statistical analysis was evaluated by ROC curve analysis. Results: The study included women aged from 50–80 years with 5–30 years of menopause. The relative concentration of C14:1, C14:2, C16:1, C18:1, and C18:2OH acylcarnitines decreased and C18 acylcarnitine and serine increased in diabetic patients compared to control. Besides, C16:1 and C18:2OH acylcarnitines increased in high-risk CVD diabetic patients compared to no CVD risk diabetic patients. Conclusion: Dysregulation of serum acylcarnitines and amino acids profile correlated with different CAC score ranges in diabetic postmenopausal women. (Ethic approval No: IR.TUMS.EMRI.REC.1399.062). © 2022, The Author(s).